A group of pediatricians and public health officials asked the agency Thursday to bar drug manufacturers from marketing such remedies as Toddler's Dimetapp, Infant Triaminic and Little Colds to children under 6.
Most over-the-counter cold and cough medicines have been insufficiently tested in children, said Ganley, the director of the FDA's office of nonprescription drug products.
Common children's cold and cough medicines are coming under scrutiny from federal drug regulators, who say the remedies and their recommended doses have not been studied enough in children, a newspaper reported.
